Mesenchymal stems have captured the attention in regenerative medicines over few decades. According to recent studies, there is no link between the <p><a href="https://kimeralabs.com/products/clinical-research-exosomes/">MSC exosome&rsquo;s clinical trials</a></p>’ pleiotropic effects and differentiation ability. Instead, the secretion of soluble paracrine factors is mediated. Exosomes, nanoscale extracellular vesicles, are a kind of paracrine mediator. Exosomes move functional cargoes like miRNA and mRNA molecules, peptides, proteins, and lipids from MSCs. Exosomes are responsible for intercellular communication and contribute to the healing of injured tissues. According to the studies, they are also responsible for the therapeutic effect of MSCs in various experimental models. MSCs derived exosomes provides more firm and decreased safety risks regarding the administration of live cells. Due to their immunomodulatory abilities, MSCs are used as a cellular therapy for treating numerous human diseases. According to the MSC exosome’s clinical trials, it is the production of the extracellular vesicles that contains protein, amino acid, and lipid that transmits signals to recipient cells. MSCs contribute to all the skin healing stages by playing an active and beneficial role in animals and humans. MSCs is a novel therapy for wound healing and regeneration, gaining momentum in the past few years.